Aurora Cannabis (ACB) Depreciation & Amortization (CF) (2017 - 2025)

Aurora Cannabis (ACB) posted quarterly Depreciation & Amortization (CF) of $1.4 million for Q1 2025, down 75.28% year-on-year from $5.6 million in Q1 2024, and down 63.49% on a QoQ basis from $3.8 million in Q4 2024.

Aurora Cannabis (ACB) Depreciation & Amortization (CF) (2017 - 2025) Analysis & Trends

Aurora Cannabis (ACB) has reported Depreciation & Amortization (CF) for 9 consecutive years, with $1.4 million the latest figure, recorded in Q1 2025.

  • Quarterly Depreciation & Amortization (CF) fell 75.28% year-over-year to $1.4 million in Q1 2025, while the trailing twelve-month figure through Dec 2025 was $1.4 million (down 91.99% YoY) and the FY2026 annual result came in at $9.7 million, down 25.62% from the prior year.
  • Depreciation & Amortization (CF) fell to $1.4 million in Q1 2025 per ACB's latest filing, from $3.8 million in the prior quarter.
  • Over the last five years, Depreciation & Amortization (CF) for ACB reached as high as $24.6 million in Q4 2022 and fell as low as $1.4 million in Q1 2025.
  • A 5-year average of $9.6 million and a median of $5.7 million in 2021 frame the typical range for Depreciation & Amortization (CF).
  • Annual changes were most pronounced in 2022 — Depreciation & Amortization (CF) jumped 87.03% — and 2023, when it tumbled 77.75%.
  • Year by year, Depreciation & Amortization (CF) stood at $14.0 million in 2021, then soared by 76.3% to $24.6 million in 2022, then slumped by 77.75% to $5.5 million in 2023, then slumped by 30.7% to $3.8 million in 2024, then sank by 63.49% to $1.4 million in 2025.
  • According to Business Quant data, Depreciation & Amortization (CF) over the past three periods registered $1.4 million, $3.8 million, and $3.8 million for Q1 2025, Q4 2024, and Q3 2024 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Depreciation & Amortization (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 239.00 Mn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 119.00 Mn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn 1.04 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 22.60 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 676.10 Mn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 7.20 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 172.00 Mn
10 Aurora Cannabis 1.11 Bn 1.03 Bn 21.72 Mn -

Historic Data

Download Data
DateValue
Mar 31, 2025 1.39 Mn
Mar 31, 2025 1.39 Mn
Dec 31, 2024 3.80 Mn
Dec 31, 2024 3.80 Mn
Sep 30, 2024 3.79 Mn
Sep 30, 2024 3.79 Mn
Jun 30, 2024 4.12 Mn
Jun 30, 2024 4.12 Mn
Mar 31, 2024 5.61 Mn
Mar 31, 2024 5.61 Mn
Dec 31, 2023 5.48 Mn
Dec 31, 2023 5.48 Mn
Sep 30, 2023 5.41 Mn
Sep 30, 2023 5.41 Mn
Dec 31, 2022 24.64 Mn
Dec 31, 2022 24.64 Mn
Sep 30, 2022 16.85 Mn
Sep 30, 2022 16.85 Mn
Jun 30, 2022 9.91 Mn
Jun 30, 2022 9.91 Mn